TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
BioInvent International AB
Closing information (x1000 SEK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
44,686
|
71,461
|
326,126 |
| Financial expenses |
649
|
1,528
|
794 |
| Earnings before taxes |
-429,240
|
-330,100
|
-42,503 |
| EBITDA |
-471,059
|
-369,942
|
-50,921 |
| Total assets |
989,236
|
1,400,180
|
1,712,214 |
| Current assets |
943,214
|
1,133,265
|
1,084,062 |
| Current liabilities |
95,206
|
75,918
|
87,319 |
| Equity capital |
885,815
|
1,309,727
|
1,606,122 |
| - share capital |
13,161
|
13,161
|
12,994 |
| Employees (average) |
112
|
104
|
89 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
89.5%
|
93.5%
|
93.8% |
| Turnover per employee |
399
|
687
|
3,664 |
| Profit as a percentage of turnover |
-960.6%
|
-461.9%
|
-13.0% |
| Return on assets (ROA) |
-43.3%
|
-23.5%
|
-2.4% |
| Current ratio |
990.7%
|
1492.7%
|
1241.5% |
| Return on equity (ROE) |
-48.5%
|
-25.2%
|
-2.6% |
| Change turnover |
-26,775
|
-254,665
|
306,742 |
| Change turnover % |
-37%
|
-78%
|
1582% |
| Chg. No. of employees |
8
|
15
|
10 |
| Chg. No. of employees % |
8%
|
17%
|
13% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.